Funds

Funds and Awards

  • Researcher Development and Travel Grant.
  • Enabling Technology Competition Winner. Royal Society of Chemistry.
  • Adventurous manufacturing Grant. Re-inventing Solid-Phase Peptide Synthesis. Merrifield 2.0. Funding agency: EPSRC. PI: Daryl Williams, Co-PI: Othman Al Musaimi
  • Research Excellence Development Award. Non-invasive Therapy for Soft Tissue Reconstruction. Funding agency: Newcastle University. PI: Othman Al Musaimi, collaborators: Keng Wooi Ng, Catharien Hilkens, and Katarina Novakovic.
  • Seeds Funds. Re-inventing solid-phase peptide synthesis. Funding agency: Imperial College London; Technical project lead: Othman Al Musaimi, business project lead: Daryl R. Williams.
  • American Peptide Symposium. Peptide at the Frontier. Scottsdale, AZ – June 24 – 29, 2023.
  • DT Prime commercialization program. Therapeutic Peptide Manufacture. Funding agency: Imperial College London; Technical project lead: Othman Al Musaimi, business project lead: Daryl R. Williams.
  • Dame Julia Higgins Engineering Postdoc Collaborative Research Fund 2022 ” Designing ATR Kinase peptide-based inhibitors as novel chemotherapeutics”: Funding agency: Imperial College London; Project lead: Luke Yates,Collaborators: Richard Kelwick. Othman Al Musaimi, Mingxia Guo.
  • 27th American Peptide Symposium. Peptide Science at the Summit. Whistler, BC – June 11 – 16, 2022.
  • Dame Julia Higgins Engineering Postdoc Collaborative Research Fund 2021 “Delivering cell-penetrating peptides non-invasively into the brain to target glial-related brain diseases”: Funding agency: Imperial College London; Project lead: Othman Al Musaimi, Collaborator: Sophie Morse.
  • Development and Validation of a New High-Performance Liquid Chromatography (HPLC) Method of Analysis for Determination of Cystatin C in human Blood:  Funding agency: King Abdulaziz City for Science and Technology (KACST); Principal investigator: Othman Al Musaimi; Institution: University of Hail; Co-investigators: Abdel Hakeem Abu Nawwas, Danah Al Shaer, Nabeel Khaleel Shehab; Secondary institution: King Fahad Medical City.